Answers are grounded in this paper and cite their sources.
Outbreak investigation reports transmission of NDM-1-producing Escherichia coli in a repurposed COVID-19 intensive care unit, highlighting the risk of hospital-acquired infections during surges.
The SARS-CoV-2 pandemic has resulted in a surge of critically ill patients. Hospitals have had to adapt to the demand by repurposing areas as intensive care units. This has resulted in high workload and disruption of usual hospital workflows. Surge capacity guidelines and pandemic response plans do not contemplate how to limit collateral damage from issues like hospital-acquired infections. It is vital to ensure quality of care in surge scenarios.
No takes yet. Share an insight, caveat, or question.
Fernández‐García et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: